CCND1 and breast cancer: Cyclin E1 is often expressed at high levels in the absence of increased cyclin D1 [80], and in fact cyclin E1-Cdk2 activity is increased by estrogen in breast cancer cells primarily through disengagement of p21Waf1/Cip1 rather than transcriptional upregulation by cyclin D1 [75].